The global generic injectables market is anticipated to grow at a significant CAGR during the forecast period (2021-2027).  The major factors that are expected to accelerate the growth of the market during the forecast period include the advantages offered by generic injectables and favorable governments initiatives are supporting the growth of the market. Moreover, an increase in drug shortages, especially in the US, along with patent expiry of a number of blockbuster drugs, aging population, and rising prevalence of chronic as well as lifestyle diseases, are some of the other factors that are anticipated to boost the growth of the market during the forecast period. Injectable usually refers to a drug delivery system and acts as an alternative to oral drugs. The generic injectable is a pharmaceutical drug with the same active ingredient as the innovator drug and is equivalent to it in terms of route of administration, intended use, performance, strength, dosage, and side effects. 

The manufacture of generic injectables is feasible only on the expiration of the patent of innovator injectables. Generic injectables are bio-equivalent of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have a similar active ingredient, dosage, strength, quality, and form. Although the manufacturing of generic injectables is complex, their R&D cycle is cost-effective and shorter. Unlike branded drug manufacturers who spend millions of dollars on R&D and marketing, generic drug manufacturers do not require such investments. Moreover, the number of competitors in the generic injectables market is lower as compared to oral generics, resulting in limited price erosion and significantly higher profit margins.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Pfizer Inc., AstraZeneca plc, and Hikma Pharmaceuticals plc, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Generic Injectables Market Report by Segment

By Therapeutic Area

• Oncology

• Anesthesia

• Anti-Infectives

• Parenteral Nutrition

• CVD

By Distribution Channel

• Hospitals

• Retail Pharmacy

Global Generic Injectables Market by Region